CoChat

Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease

Open access
Bobkova, Natalia V., Garbuz, David G., Nesterova, Inna, Medvinskaya, Natalia, Samokhin, Alexander, Alexandrova, Irina, Yashin, Valerii, Karpov, Vadim, Kukharsky, Michail S., Ninkina, Natalia N., Smirnov, Andrey A., Nudler, Evgeny, Evgen'ev, Michael · 2013 · Journal of Alzheimer's Disease

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Brain deterioration resulting from "protein folding" diseases, such as the Alzheimer's disease (AD), is one of the leading causes of morbidity and mortality in the aging human population. Heat shock proteins (Hsps) constitute the major cellular quality control system for proteins that mitigates the pathological burden of neurotoxic protein fibrils and aggregates. However, the therapeutic effect of Hsps has not been tested in a relevant setting. Here we report the dramatic neuroprotective effect of recombinant human Hsp70 in the bilateral olfactory bulbectomy model (OBX mice) and 5XFAD mouse models of neurodegeneration. We show that intranasally-administered Hsp70 rapidly enters the afflicted brain regions and mitigates multiple AD-like morphological and cognitive abnormalities observed in model animals. In particular, in both cases it normalizes the density of neurons in the hippocampus and cortex which correlates with the diminished accumulation of amyloid-β (Aβ) peptide and, in the case of 5XFAD mice, reduces Aβ plaque formation. Consistently, Hsp70 treatment also protects spatial memory in OBX and 5XFAD mice. These studies demonstrate that exogenous Hsp70 may be a practical therapeutic agent for treatment of neurodegenerative diseases associated with abnormal protein biogenesis and cognitive disturbances, such as AD, for which neuroprotective therapy is urgently needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-130779

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 4

  1. [2][2] Reisberg B, Saeed MU (2004) Alzheimer's disease. In Comprehensive Textbook of Geriatric Psychiatry, 3rd edition, Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. WW Norton, New York, pp. 449-509. -
  2. [11][11] Bobkova NV, Nesterova I, Medvinskaya N, Samokhin A, Alexandrova I (2005) Possible role of the olfactory system in Alzheimer's disease genesis. In New Trends in Alzheimer and Parkinson Disorders: ADPD 2005 , Fisher A, Hanin I, Memo M, Stocchi F, eds. Medimond, Sorento, pp. 91-95. -
  3. [20][20] Wilson MC, et al. (1994) Regulation of the olfactory bulb Alzheimer's precursor protein (APP) by lesioning of the olfactory bulb. Soc Neurosci 509 (8), 1249. -
  4. [34][34] Margulis B, Kinev A, Guzhova I (2006) Chaperones in neurodegenerative pathologies: Therapeutic prospects. In Heat Shock Proteins in Biology and Medicine , Radons J, Multhoff G, eds. Research Signpost, Kerala, pp. 305-329. -

Cited by

See all 138

Metadata

Authors
Bobkova, N. V., Garbuz, D. G., Nesterova, I., Medvinskaya, N., Samokhin, A., Alexandrova, I., Yashin, V., Karpov, V., Kukharsky, M. S., Ninkina, N. N., Smirnov, A. A., Nudler, E., & Evgen'ev, M.
Affiliations
  • Institute of Cell Biophysics, RAS, Pushchino, Moscow region, Russia
  • Engelhardt Institute of Molecular Biology (RU)
  • Institute of Cell Biophysics (RU)
  • Engelhardt Institute of Molecular Biology, Moscow, Russia
  • Institute of Physiologically Active Compounds (RU)
  • Cardiff University (GB)
  • Institute of Theoretical and Experimental Biophysics (RU)
  • New York University (US)
Corresponding author
Nudler, Evgeny
Venue
Journal of Alzheimer's Disease
Published
2013-11-13
Volume
38
Issue
2
Pages
425-435
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1899777911
Cited by
138
References
45
Citations by year
2026: 10 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 7 · 2019: 12 · 2018: 14 · 2017: 12 · 2016: 16 · 2015: 14 · 2014: 7 · 2013: 1
FWCI
8.80
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
Funders
  • Bethlehem Griffiths Research Foundation
  • Russian Foundation for Basic Research
  • Dynasty Foundation
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
HSP70, Alzheimer's disease
MeSH terms
Administration, Intranasal, Alzheimer Disease, Animals, Olfaction Disorders, Cerebral Cortex, Disease Models, Animal, Hippocampus, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Olfactory Bulb, Amyloid beta-Protein Precursor, HSP70 Heat-Shock Proteins, Mice, Presenilin-1, Amyloidogenic Proteins, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease. https://app.cochat.ai/papers/10.3233/jad-130779
The paper
Bobkova, N. V., Garbuz, D. G., Nesterova, I., Medvinskaya, N., Samokhin, A., Alexandrova, I., Yashin, V., Karpov, V., Kukharsky, M. S., Ninkina, N. N., Smirnov, A. A., Nudler, E., & Evgen'ev, M. (2013). Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-130779

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.